Pathological diagnosis of bladder cancer by image analysis of hypericin induced fluorescence cystoscopic images

Photodynamic diagnosis of bladder carcinoma based on hypericin fluorescence cystoscopy has shown to have a higher degree of sensitivity for the detection of flat bladder carcinoma compared to white light cystoscopy. The potential of the photosensitizer hypericin-induced fluorescence in performing non-invasive optical biopsy to grade bladder cancer in vivo using fluorescence cystoscopic image analysis without surgical resection for tissue biopsy is investigated in this study. The correlation between tissue fluorescence and histopathology of diseased tissue was explored and a diagnostic algorithm based on fluorescence image analysis was developed to classify the bladder cancer without surgical resection for tissue biopsy. Preliminary results suggest a correlation between tissue fluorescence and bladder cancer grade. By combining both the red-to-blue and red-to-green intensity ratios into a 2D scatter plot yields an average sensitivity and specificity of around 70% and 85% respectively for pathological cancer grading of the three different grades of bladder cancer. Therefore, the diagnostic algorithm based on colorimetric intensity ratio analysis of hypericin fluorescence cystoscopic images developed in this preliminary study shows promising potential to optically diagnose and grade bladder cancer in vivo.

[1]  D M Parkin,et al.  Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. , 1997, European journal of cancer.

[2]  L. Baert,et al.  Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. , 2000, The Journal of urology.

[3]  François Guillemin,et al.  Fluorescence detection of bladder cancer: a review. , 2002, European urology.

[4]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[5]  L. Kiemeney,et al.  Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. , 1993, The Journal of urology.

[6]  K. Soo,et al.  Detection of squamous cell carcinomas and pre‐cancerous lesions in the oral cavity by quantification of 5‐aminolevulinic acid induced fluorescence endoscopic images , 2002, Lasers in surgery and medicine.

[7]  P. Tan,et al.  Macro-microscopic fluorescence of human bladder cancer using hypericin fluorescence cystoscopy and laser confocal microscopy. , 2003, International journal of oncology.

[8]  S. Okpanyi,et al.  [Genotoxicity of a standardized Hypericum extract]. , 1990, Arzneimittel-Forschung.

[9]  C. Muir,et al.  Cancer incidence in Singapore , 1967 .

[10]  M. Olivo,et al.  Fluorescence confocal microscopy and image analysis of bladder cancer using 5-aminolevulinic acid. , 2003, International journal of oncology.

[11]  K. Syrigos,et al.  Role of adhesion molecules in bladder cancer: an important part of the jigsaw. , 1999, Urology.

[12]  J. Rassweiler,et al.  Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. , 2002, The Journal of urology.

[13]  D. Meruelo,et al.  The chemical and biological properties of hypericin—a compound with a broad spectrum of biological activities , 1995, Medicinal research reviews.

[14]  C. Mulrow,et al.  St John's wort for depression—an overview and meta-analysis of randomised clinical trials , 1996, BMJ.

[15]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  E. Sevick-Muraca,et al.  Quantitative optical spectroscopy for tissue diagnosis. , 1996, Annual review of physical chemistry.

[17]  T. Roskams,et al.  Hypericin‐based fluorescence diagnosis of bladder carcinoma , 2002, BJU international.

[18]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 1995. , 2002, European journal of cancer.

[19]  D. Lamm,et al.  Chemoprevention of urological cancer. , 1999, The Journal of urology.